Sialic acid analogs
US-9221858-B2 · Dec 29, 2015 · US
US9650404B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9650404-B2 |
| Application number | US-201113581020-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 25, 2011 |
| Priority date | Feb 26, 2010 |
| Publication date | May 16, 2017 |
| Grant date | May 16, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to novel curcumin derivatives in which one or two of the phenolic groups have been modified.
Opening claim text (preview).
The invention claimed is: 1. A curcumin derivative having the formula I: wherein: A is —CH 2 —CH 2 — or —CH═CH—; R 1 represents L 1 m1 -Y 1 ; R 2 represents L 2 m2 -Y 2 ; L 1 and L 2 are m1 and m2 are 1; n1 is independently 0 or an integer from 1 to 50; Y 1 and Y 2 independently represent a saccharide with 1 to 51 monosaccharide units; CH 2 —CH═CH 2 or CH 2 —C═CH; R 3 independently represents a saturated, unbranched hydrocarbyl with 1 to 4 carbon atoms and n2 independently represents an integer from 5 and 50. 2. A curcumin derivative according to claim 1 , wherein L 1 is and Y 1 is a saccharide. 3. A curcumin derivative according to claim 2 , wherein the saccharide is a monosaccharide. 4. A curcumin derivative according to claim 3 , wherein the monosaccharide is glucose or galactose. 5. A curcumin derivative according to claim 1 , wherein Y 1 or Y 2 is a saccharide. 6. A curcumin derivative according to claim 1 , wherein Y 1 or Y 2 is a disaccharide or a trisaccharide. 7. A curcumin derivative according to claim 1 , wherein the saccharide is a monosaccharide. 8. A curcumin derivative according to claim 1 , wherein the monosaccharide is glucose or galactose. 9. A method of treating Alzheimer's disease in a patient comprising administering to the patient in need thereof a therapeutically effective amount of a curcumin derivative having the formula I: wherein: A is —CH 2 —CH 2 — or —CH═CH—; R 1 represents L 1 m1 -Y 1 ; R 2 represents L 2 m2 -Y 2 ; L 1 and L 2 are m1 and m2 are 1; n1 is independently 0 or an integer from 1 to 50; Y 1 and Y 2 independently represent a saccharide with 1 to 51 monosaccharide units; CH 2 —CH═CH 2 or CH 2 —C═CH; R 3 independently represents a saturated, unbranched hydrocarbyl with 1 to 4 carbon atoms; and n2 independently represents an integer from 5 and 50.
Heterocyclic radicals · CPC title
1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles · CPC title
Glutaric acid esters · CPC title
containing ether groups, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] groups · CPC title
containing five-membered rings with nitrogen as a ring hetero atom · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.